Risk of Barrett's esophagus progression to esophageal adenocarcinoma.
作者信息
Kota Lahari, Tyberg Amy
机构信息
Department of Internal Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.
Division of Advanced and Therapeutic Endoscopy, Department of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.
出版信息
Clin Endosc. 2024 Nov;57(6):763-764. doi: 10.5946/ce.2024.273. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Risk of Barrett's esophagus progression to esophageal adenocarcinoma.巴雷特食管发展为食管腺癌的风险。
Clin Endosc. 2024 Nov;57(6):763-764. doi: 10.5946/ce.2024.273. Epub 2024 Nov 25.
2
Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?基于非异型增生内镜检查次数，巴雷特食管进展为食管腺癌的风险是否会改变？
Dig Dis Sci. 2021 Jun;66(6):1965-1973. doi: 10.1007/s10620-020-06483-0. Epub 2020 Jul 20.
3
MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.巴雷特食管到食管腺癌恶性进展过程中的 microRNA 表达特征。
Cancer Prev Res (Phila). 2013 Mar;6(3):196-205. doi: 10.1158/1940-6207.CAPR-12-0276.
4
Surveillance of Barrett's Esophagus Patients in an Expert Center is Associated With Low Disease-Specific Mortality.在一个专家中心对巴雷特食管患者进行监测与较低的疾病特异性死亡率相关。
United European Gastroenterol J. 2025 Mar;13(2):220-228. doi: 10.1002/ueg2.12759. Epub 2025 Feb 13.
5
Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.一级亲属患有食管腺癌会增加 Barrett 食管患者患食管腺癌的风险。
United European Gastroenterol J. 2019 Mar;7(2):225-229. doi: 10.1177/2050640618817098. Epub 2018 Nov 29.
6
Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.巴雷特食管和食管腺癌风险的测定。
Curr Opin Gastroenterol. 2016 Jul;32(4):319-24. doi: 10.1097/MOG.0000000000000274.
7
Barrett's esophagus and risk of esophageal adenocarcinoma.巴雷特食管与食管腺癌风险
Semin Gastrointest Dis. 2003 Jul;14(3):128-35.
8
Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.反流控制在巴雷特食管的管理中很重要：来自1830例患者回顾性队列研究的结果
Surg Endosc. 2015 Dec;29(12):3528-34. doi: 10.1007/s00464-015-4103-3. Epub 2015 Feb 13.
9
Cancer Risk in Barrett's Esophagus: A Clinical Review.巴雷特食管中的癌症风险：临床综述。
Int J Mol Sci. 2023 Mar 23;24(7):6018. doi: 10.3390/ijms24076018.
10
Risk factors, DNA damage, and disease progression in Barrett's esophagus.巴雷特食管的危险因素、DNA损伤与疾病进展
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5. doi: 10.1158/1055-9965.EPI-04-0509.
引用本文的文献
1
A bidirectional Mendelian randomization study integrating genome-wide association studies, expression quantitative trait locus, and methylation quantitative trait locus data revealed causal relationship between heavy cigarette dependence and Barrett's esophagus.一项整合全基因组关联研究、表达数量性状基因座和甲基化数量性状基因座数据的双向孟德尔随机化研究揭示了重度香烟依赖与巴雷特食管之间的因果关系。
SAGE Open Med. 2025 Feb 7;13:20503121251316595. doi: 10.1177/20503121251316595. eCollection 2025.
本文引用的文献
1
Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett's esophagus: a retrospective cohort study in Sweden.与巴雷特食管中发育异常降级为非发育异常化生的患者相比，确诊为发育异常的患者进展为癌症的情况：瑞典的一项回顾性队列研究。
Clin Endosc. 2024 Nov;57(6):768-774. doi: 10.5946/ce.2023.313. Epub 2024 Nov 25.
2
AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.AGA 临床实践指南： Barrett 食管及相关肿瘤的内镜消除治疗。
Gastroenterology. 2024 Jun;166(6):1020-1055. doi: 10.1053/j.gastro.2024.03.019.
3
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Barrett 食管的诊断和管理：ACG 指南更新。
Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680.
4
Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis.Barrett 食管不典型增生进展风险不明：系统评价和荟萃分析。
Gastrointest Endosc. 2020 Jan;91(1):3-10.e3. doi: 10.1016/j.gie.2019.07.037. Epub 2019 Aug 14.
5
Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.内镜下 Barrett 食管的处理：欧洲胃肠道内镜学会（ESGE）立场声明。
Endoscopy. 2017 Feb;49(2):191-198. doi: 10.1055/s-0042-122140. Epub 2017 Jan 25.
6
Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.澳大利亚巴雷特食管和早期食管腺癌诊断与管理临床实践指南。
J Gastroenterol Hepatol. 2015 May;30(5):804-20. doi: 10.1111/jgh.12913.
7
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.英国胃肠病学会 Barrett 食管诊断和管理指南。
Gut. 2014 Jan;63(1):7-42. doi: 10.1136/gutjnl-2013-305372. Epub 2013 Oct 28.
8
Incidence of adenocarcinoma among patients with Barrett's esophagus.巴雷特食管患者腺癌的发病率。
N Engl J Med. 2011 Oct 13;365(15):1375-83. doi: 10.1056/NEJMoa1103042.
9
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review.食管腺癌中Barrett食管的术前患病率：一项系统评价
Gastroenterology. 2002 Jan;122(1):26-33. doi: 10.1053/gast.2002.30297.
Zotero 插件